REC: CardioClinicsPub Date : 2026-01-01Epub Date: 2025-09-16DOI: 10.1016/j.rccl.2025.08.006
Alberto Guevara Tirado
{"title":"Rol mediador de la gamma-glutamil transferasa en el vínculo entre disfunción ventricular y función sistólica","authors":"Alberto Guevara Tirado","doi":"10.1016/j.rccl.2025.08.006","DOIUrl":"10.1016/j.rccl.2025.08.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Heart failure involves multiorgan dysfunction; the heart–liver axis underlies the concept of the cardiohepatic syndrome. This study evaluated gamma-glutamyl transferase (GGT) as a mediator between left ventricular dysfunction and systolic function.</div></div><div><h3>Methods</h3><div>A cross-sectional analysis was performed using secondary data from 567 patients hospitalized for heart failure. The relationships between left ventricular end-diastolic diameter (LVEDD), GGT, and left ventricular ejection fraction (LVEF) were assessed using Hayes’ PROCESS mediation model 4. Multiple linear regressions were adjusted for comorbidities and clinical variables. The indirect effect was estimated through bootstrap resampling with 5000 iterations. A directed acyclic graph was used to represent the causal hypothesis.</div></div><div><h3>Results</h3><div>A significant association was observed between LVEDD and GGT (<em>B</em> <!-->=<!--> <!-->5.13; <em>P</em>=.044), suggesting a direct link between cardiac impairment and increased hepatic marker levels. GGT was inversely associated with LVEF (<em>B</em> <!-->=<!--> <!-->−0.021; <em>P</em>=.009), and LVEDD also showed a negative association with LVEF (<em>B</em> <!-->=<!--> <!-->−2.40; <em>P</em><.001). Mediation analysis revealed a significant indirect effect of LVEDD on LVEF through GGT (−0.11; 95%CI: −0.23 to −0.005), supporting the mediating role of this enzyme in the cardiohepatic axis.</div></div><div><h3>Conclusions</h3><div>GGT may act as a mediator between ventricular dysfunction and reduced LVEF in patients hospitalized with heart failure, reflecting a clinically relevant cardiohepatic interaction.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 24-31"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
REC: CardioClinicsPub Date : 2026-01-01Epub Date: 2025-09-20DOI: 10.1016/j.rccl.2025.08.004
Francisco J. Chorro , Adolfo Alonso-Arroyo , Cristina I. Font-Julián , Yiming Liu , Rafael Aleixandre-Benavent
{"title":"Características y evolución de la concesión de patentes en el área cardiovascular en España","authors":"Francisco J. Chorro , Adolfo Alonso-Arroyo , Cristina I. Font-Julián , Yiming Liu , Rafael Aleixandre-Benavent","doi":"10.1016/j.rccl.2025.08.004","DOIUrl":"10.1016/j.rccl.2025.08.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Updated analysis of patent grants related to cardiovascular diseases (CVD) in Spain.</div></div><div><h3>Methods</h3><div>Development of a search process for patents related to CVD in the Global Patent Index, review of those granted in Spain, and standardization. Analysis of their evolution over time, origin, collaborations, types, and thematic distribution.</div></div><div><h3>Results</h3><div>Identification of 1870 patents (1909-2023), whose growth has been exponential (n<!--> <!-->=<!--> <!-->1.687 exp [0.066*years; <em>P</em><.001). They come from 1107 applicants from 39 countries, 616 from Spain who have originated 923 patents, followed by Germany (293), Switzerland (177), France (92) and the Netherlands (81). Collaborations are present in 15.2%. Seven networks have involved ≥ 3 applicants with ≥ 2 collaborations. The most frequent subject has been “pharmacological treatments” (38%), and in this group “antihypertensives”. Since 1992, translations of European patents have increased, and are currently the most common type. The proportions by thematic group have varied significantly (<em>P</em><.001), with more recent increases in those related to “catheters/devices” and “diagnostic/monitoring techniques” and decreases in “pharmacological treatments” and “biochemistry/molecular biology”.</div></div><div><h3>Conclusions</h3><div>Patents related to CVD in Spain originate mainly in Europe. 15.2% are requested in collaboration. The highest number corresponds to Spain, followed by Germany, Switzerland, France, and the Netherlands. The most frequent subject has been “antihypertensive treatments”. Overall, the largest increase in grants (close to 40%) occurred in the decade 2010-2020, especially related to the translation of European patents. The subjects that are growing the most in the 21st century are those related to “catheters/devices” and “diagnostic/monitoring techniques”.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 41-56"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Desenmascarando el gradiente oculto: el papel de la ecocardiografía de esfuerzo en la miocardiopatía hipertrófica","authors":"Noemí Ramos López , Jesús González Mirelis , Esther González-López","doi":"10.1016/j.rccl.2025.10.004","DOIUrl":"10.1016/j.rccl.2025.10.004","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 4-6"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
REC: CardioClinicsPub Date : 2026-01-01Epub Date: 2025-08-12DOI: 10.1016/j.rccl.2025.07.006
Juan Geraldo-Martínez , Alba Corralejo-del-Peso , Virginia Ruiz-Pizarro , Marta Alamar-Cervera , Jorge Álvarez-Rubio , Joan Torres-Marqués , Esther Moranta-Ribas , David Crémer-Luengos , Carlos Veras-Burgos , María Monserrat-Companys , Tomás Ripoll-Vera
{"title":"Utilidad del ecocardiograma de esfuerzo en la valoración de pacientes con miocardiopatía hipertrófica","authors":"Juan Geraldo-Martínez , Alba Corralejo-del-Peso , Virginia Ruiz-Pizarro , Marta Alamar-Cervera , Jorge Álvarez-Rubio , Joan Torres-Marqués , Esther Moranta-Ribas , David Crémer-Luengos , Carlos Veras-Burgos , María Monserrat-Companys , Tomás Ripoll-Vera","doi":"10.1016/j.rccl.2025.07.006","DOIUrl":"10.1016/j.rccl.2025.07.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>One-third of patients with hypertrophic cardiomyopathy (HCM) present left ventricular outflow tract obstruction at rest. However, a significant percentage of patients show latent obstruction. Exercise echocardiography is valuable for detecting this hidden gradient. The aim of this study is to analyze predictors of latent left ventricular outflow tract obstruction and its prognostic implications.</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective study in 150 patients diagnosed with HCM according to European Society of Cardiology criteria, all of whom underwent exercise echocardiography. Demographic, clinical, echocardiographic, and long-term adverse event data were collected. Characteristics of patients with and without latent obstruction were compared, and prognostic factors associated with severe events were examined.</div></div><div><h3>Results</h3><div>Resting obstruction was present in 9% of the cohort, while 24% exhibited latent obstruction. Absence of atrial fibrillation, the use of beta-blockers or disopyramide, and an elevated baseline or post-Valsalva gradient were associated with latent obstruction. Neither latent obstruction nor gradient magnitude correlated with adverse events. Worse prognosis was linked to older age, increased ventricular wall thickness, New York Heart Association functional class<!--> <!-->III or<!--> <!-->IV, and use of beta-blockers or disopyramide.</div></div><div><h3>Conclusions</h3><div>Exercise echocardiography is a safe and useful method for detecting latent obstruction in HCM patients. Although the induced gradient did not correlate with prognosis, identifying it could enhance overall patient assessment.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 16-23"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
REC: CardioClinicsPub Date : 2026-01-01Epub Date: 2025-06-24DOI: 10.1016/j.rccl.2025.06.002
Joaquín Osca Asensi , Josep Navarro-Manchón , María Teresa Izquierdo de Francisco , Óscar Cano Pérez , Javier Navarrete Navarro , Carmen Arveras Martínez , Francisco Javier Chorro Gascó , Luis Martínez-Dolz
{"title":"Aislamiento de venas pulmonares en fibrilación auricular paroxística y persistente. Electroporación o radiofrecuencia","authors":"Joaquín Osca Asensi , Josep Navarro-Manchón , María Teresa Izquierdo de Francisco , Óscar Cano Pérez , Javier Navarrete Navarro , Carmen Arveras Martínez , Francisco Javier Chorro Gascó , Luis Martínez-Dolz","doi":"10.1016/j.rccl.2025.06.002","DOIUrl":"10.1016/j.rccl.2025.06.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Pulsed-field ablation (PFA) has emerged as an alternative to radiofrequency and cryoablation for pulmonary vein isolation (PVI). The effectiveness and safety of PFA versus radiofrequency for PVI is not sufficiently studied.</div></div><div><h3>Methods</h3><div>Unicentric and retrospective study. Consecutive patients with paroxysmal or persistent atrial fibrillation undergoing PVI with PFA or radiofrequency in 2 historical cohorts were included. The primary outcome was recurrence of any atrial arrhythmia after a 90-day blanking period. Patients underwent usual clinical follow-up.</div></div><div><h3>Results</h3><div>A total of 374 patients were remitted to PVI (198 to PFA and 176 to radiofrequency). At 1 year 82,3% were free of auricular arrhythmias in PFA versus 82,4% in radiofrequency (<em>P</em> <!-->=<!--> <!-->.862). Looking at the type of atrial fibrillation (paroxysmal/persistent) the long-term outcomes were also similar. Median procedure time was significantly shorter in PFA (73 vs 141<!--> <!-->minutes; <em>P</em> <!-->=<!--> <!-->.001). However, fluoroscopy time was significantly longer in PFA (13 vs 5<!--> <!-->minutes; <em>P</em> <!-->=<!--> <!-->.001). Adverse events were similar in both cohorts. Organized atrial arrhythmias after PVI were similar in both groups (26% of recurrence). Recurrences were related to different factors in univariate buy were only related to early recurrence (blanking period) in multivariate analysis (OR, 4,24; 95%CI, 2,46-7,33; <em>P</em> <!-->=<!--> <!-->.0001).</div></div><div><h3>Conclusions</h3><div>PFA compared with radiofrequency PVI shows a similar procedural effectiveness but is associated with shorter procedure time and longer fluoroscopy. Organized atrial arrhythmias after PVI were similar.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 7-15"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
REC: CardioClinicsPub Date : 2026-01-01Epub Date: 2025-11-28DOI: 10.1016/j.rccl.2025.10.005
María Dolores Masiá Mondéjar , Isabel López-Ruiz , Juan Quiles , Lara Sánchez Suárez , Olivia Rubio Sanz , Javier Roibal Pravio , Rocío Álvarez Bernabéu , Maia Brik , Manuel Gallando Brejano , Juan Ramón Heredia-Elvar , Araceli Boraita
{"title":"El papel del ejercicio físico en la salud cardiovascular de la mujer. Documento de posicionamiento de SEC-Asociación de Cardiología Preventiva/SEC-GT Ejercicio Físico y Salud Cardiovascular","authors":"María Dolores Masiá Mondéjar , Isabel López-Ruiz , Juan Quiles , Lara Sánchez Suárez , Olivia Rubio Sanz , Javier Roibal Pravio , Rocío Álvarez Bernabéu , Maia Brik , Manuel Gallando Brejano , Juan Ramón Heredia-Elvar , Araceli Boraita","doi":"10.1016/j.rccl.2025.10.005","DOIUrl":"10.1016/j.rccl.2025.10.005","url":null,"abstract":"<div><div>Cardiovascular disease remains the leading cause of death in women worldwide. Ischemic heart disease and stroke are responsible for more than 8<!--> <!-->million deaths per year in this population. The practice of physical exercise is associated with multiple benefits for women's health and fitness, across the lifespan. These benefits are strongly supported by scientific evidence: physical exercise can prevent and treat numerous noncommunicable diseases, including cardiovascular disease. Therefore, the aim of this position statement document, endorsed by the Working Group on Physical Exercise and Cardiovascular Health, the strategic project Woman and Heart, and the Association of Preventive Cardiology of the Spanish Society of Cardiology (SEC), was to review the scientific and practical knowledge regarding exercise interventions in women's cardiovascular health, in order to establish solid and rigorous criteria for health professionals. This document provides the necessary tools to design training programs for this population that ensure individualized prescription according to each woman's specific needs.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"61 1","pages":"Pages 57-67"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
REC: CardioClinicsPub Date : 2025-10-01Epub Date: 2025-06-24DOI: 10.1016/j.rccl.2025.05.001
Raúl Gascueña , Carlos de Blas , Carlos Carrasco , Julia Gómez , Rocío Ruesgas , Juan Manuel Grande
{"title":"Determinantes e impacto de la mala calidad del sueño en los pacientes hospitalizados por problemas cardiológicos","authors":"Raúl Gascueña , Carlos de Blas , Carlos Carrasco , Julia Gómez , Rocío Ruesgas , Juan Manuel Grande","doi":"10.1016/j.rccl.2025.05.001","DOIUrl":"10.1016/j.rccl.2025.05.001","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>To evaluate the prevalence and consequences of sleep disorders in hospitalized cardiology patients and identify clinical and psychosocial predictors in order to improve their detection and subsequent management.</div></div><div><h3>Methods</h3><div>Anxiety and depression (HADS scale), quality of life (SF-12 questionnaire) and sleep quality (Pittsburgh Sleep Quality Index [PSQI]) were evaluated in consecutive cardiological hospitalized patients. The duration of hospitalization and events during the year following admission were prospectively collected.</div></div><div><h3>Results</h3><div>A total of 100 consecutive patients were included (58% male, median age 74.4 years). 77% had poor sleep quality (PSQI<!--> <!-->><!--> <!-->5), a lower physical SF-12 score (Δ 5.75; 95%CI, 1.0-10.5; <em>P</em> <!-->=<!--> <!-->.019), a longer hospitalization (6.8; 95%CI, 5.1-8.5 versus 9.8; 95%CI, 7.7-11.9 days; <em>P</em> <!-->=<!--> <!-->.032) and more non-cardiological emergencies (adjusted HR, 3.24; 95%CI, 1.09-6.66; <em>P</em> <!-->=<!--> <!-->.035]. Their income level and household equipment were poorer, they received more antidepressants and 3 more drugs per day. The predictors of a PSQI<!--> <!-->><!--> <!-->5 were previous antidepressant treatment (OR, 5,53; 95%CI, 1.13-26.97; <em>P<!--> </em>=<!--> <!-->.012) and anxiety (OR, 1,3; 95%CI, 1.1-1.6; <em>P</em> <!-->=<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>Poor sleep quality is very prevalent in cardiological hospitalized patients. It decreases physical quality of life, prolongs hospitalization and predicts more visits to the emergency department. Its predictors are anxiety and previous antidepressant treatment, and it is associated with a lower income level and an uncomfortable home.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 4","pages":"Pages 253-262"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145340518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}